TriSalus Life Sciences (TLSI) Tax Provisions (2022 - 2026)
TriSalus Life Sciences' (TLSI) quarterly Tax Provisions came in at $4000.0 in Q1 2026, down 20.0% year-on-year from $5000.0 in Q1 2025, and down 20.0% quarter-over-quarter from $5000.0 in Q3 2025.
TriSalus Life Sciences (TLSI) Tax Provisions (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Tax Provisions history runs 5 years deep, the most recent figure standing at $4000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 20.0% year-over-year to $4000.0 in Q1 2026; TTM through Mar 2026 was $6000.0, a 25.0% decrease from a year earlier, with the FY2025 full-year figure at $7000.0, up 16.67% from the prior year.
- Tax Provisions eased to $4000.0 in Q1 2026 per TLSI's latest filing, from $5000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $28202.0 in Q2 2022 and bottomed at -$5000.0 in Q1 2023.
- The 5-year median for Tax Provisions is $4000.0 (2026), against an average of $4630.9.
- Across the five-year window, Tax Provisions sank 200.0% in 2024 and jumped 266.67% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $6000.0 in 2022, then tumbled by 83.33% to $1000.0 in 2023, then sank by 200.0% to -$1000.0 in 2024, then soared by 600.0% to $5000.0 in 2025, then dropped by 20.0% to $4000.0 in 2026.
- Per Business Quant, the three latest TLSI Tax Provisions figures stand at $4000.0 (Q1 2026), $5000.0 (Q3 2025), and -$3000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Jun 30, 2022 | 28,202.00 |